Aleksandar Danilovski
Directeur/Bestuurslid bij ACTIVE BIOTECH AB
Actieve functies van Aleksandar Danilovski
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ACTIVE BIOTECH AB | Directeur/Bestuurslid | 01-01-2020 | - |
| Independent Dir/Board Member | 01-01-2020 | - | |
Xellia Pharmaceuticals ApS
 Xellia Pharmaceuticals ApS Medical/Nursing ServicesHealth Services Xellia Pharmaceuticals ApS manufactures pharmaceutical products. Its products include pharmaceutical ingredients, finished dosage forms and novel anti infective pipeline. The company was founded in 1959 and is headquartered in Copenhagen, Denmark. | Hoofd Techniek/Wetenschap/O&O | 01-01-2020 | - |
| Pharmaero ApS | Directeur/Bestuurslid | - | - |
Loopbaan van Aleksandar Danilovski
Eerdere bekende functies van Aleksandar Danilovski
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| PLIVA Pharmaceuticals, Inc. | Corporate Officer/Principal | - | - |
Barr Laboratories, Inc.
 Barr Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Barr Laboratories, Inc. develops and markets generic pharmaceuticals. The company was founded by Edwin A. Cohen in 1970 and is headquartered in Montvale, NJ. | Corporate Officer/Principal | - | - |
Novo Holdings A/S (Investment Company)
 Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings A/S (Investment Company) (Novo Holdings-IC) is the investment portfolio division of Novo Holdings A/S, a holding company headquartered in Hellerup, Denmark. They are ultimately owned by Novo Nordisk Fonden (Novo Nordisk Foundation). Founded in 1999, Novo Holdings-IC manages a broad portfolio of the Foundation’s financial assets. | Corporate Officer/Principal | - | - |
| PLIVA Croatia Ltd. | Directeur/Bestuurslid | 09-01-2012 | - |
| Corporate Officer/Principal | - | 09-01-2012 | |
| The Barr Group, Inc. | Corporate Officer/Principal | 01-01-1994 | - |
PLIVA, Inc.
 PLIVA, Inc. Drugstore ChainsRetail Trade PLIVA, Inc. develops, produces, and sells drugs and pharmaceutical products. Its products include Ethosuximide, Fluoxetine, and Cyclosporine. The company was founded in 1921 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 01-01-1994 | - |
Opleiding van Aleksandar Danilovski
| University of Cambridge | Doctorate Degree |
| University of Zagreb | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
| Zweden | 3 |
| Verenigd Koninkrijk | 3 |
Operationeel
| Corporate Officer/Principal | 6 |
| Director/Board Member | 3 |
| Doctorate Degree | 2 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
| Retail Trade | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ACTIVE BIOTECH AB | Health Technology |
| Bedrijven in privébezit | 8 |
|---|---|
PLIVA, Inc.
PLIVA, Inc. Drugstore ChainsRetail Trade PLIVA, Inc. develops, produces, and sells drugs and pharmaceutical products. Its products include Ethosuximide, Fluoxetine, and Cyclosporine. The company was founded in 1921 and is headquartered in East Hanover, NJ. | Retail Trade |
Barr Laboratories, Inc.
Barr Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Barr Laboratories, Inc. develops and markets generic pharmaceuticals. The company was founded by Edwin A. Cohen in 1970 and is headquartered in Montvale, NJ. | Health Technology |
| PLIVA Pharmaceuticals, Inc. | |
Xellia Pharmaceuticals ApS
Xellia Pharmaceuticals ApS Medical/Nursing ServicesHealth Services Xellia Pharmaceuticals ApS manufactures pharmaceutical products. Its products include pharmaceutical ingredients, finished dosage forms and novel anti infective pipeline. The company was founded in 1959 and is headquartered in Copenhagen, Denmark. | Health Services |
| The Barr Group, Inc. | |
| PLIVA Croatia Ltd. | |
Novo Holdings A/S (Investment Company)
Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings A/S (Investment Company) (Novo Holdings-IC) is the investment portfolio division of Novo Holdings A/S, a holding company headquartered in Hellerup, Denmark. They are ultimately owned by Novo Nordisk Fonden (Novo Nordisk Foundation). Founded in 1999, Novo Holdings-IC manages a broad portfolio of the Foundation’s financial assets. | Finance |
| Pharmaero ApS |
